Intensive hospital monitoring of Shuxuening injection in 30 209 cases.
10.19540/j.cnki.cjcmm.20170705.012
- Author:
Jun-Jie JIANG
1
;
Yan-Ming XIE
1
;
Yin ZHANG
1
;
Ming-Quan LI
2
;
Yu-Bin ZHAO
3
;
Ze-Huai WEN
4
;
Xue-Lin LI
5
;
Dan-Hui YI
2
;
Yi-Kai ZHANG
6
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130618, China.
3. Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 052560, China.
4. Guangdong Province Traditional Chinese Medical Hospital, Guangzhou 511740, China.
5. The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 452486, China.
6. College of Statistics, Renmin University of China, Beijing 100872, China.
- Publication Type:Journal Article
- Keywords:
Shuxuening injection;
adverse reactions;
intensive hospital monitoring;
safety
- From:
China Journal of Chinese Materia Medica
2017;42(15):2883-2888
- CountryChina
- Language:Chinese
-
Abstract:
In order to obtain the characteristics and incidence of adverse reactions of Shuxuening injection (Xingxue), the design method of a multi-center, large sample intensive monitoring in the hospitals was adopted. The hospitalized patients with use of Shuxuening injection from 27 medical institutions were enrolled as the research subjects to monitor their entire process of treatment cycle. The main content of monitoring included the patients' general information, diagnostic information, medication information, and adverse event information. A total of 30 209 patients with Shuxuening injection were enrolled; adverse reactions occurred in 34 cases, with an incidence of 0.113%, which belonged to the rare adverse reactions. Adverse reactions were characterized by headache, dizziness, pruritus, palpitations, nausea, et al. All the above results showed that Xingxue Shuxuening injection had high safety in clinical application.
